2025 ZGC Forum: Gala for Global Sci-tech Cooperation
BEIJING, April 7, 2025 /PRNewswire/ -- A report from Science and Technology Daily: The 2025 Zhongguancun Forum Annual Conference (2025 ZGC Forum), with a focus on new quality productive forces, concluded on March 31, with significant results and promotion of international sci-tech cooperation.   AI and humanoid robots caught the eye AI, as a representative of new quality...
DOSIsoft PLANET® Onco Dose receives CE MDR Mark and new FDA 510(k) clearance
PARIS, April 7, 2025 /PRNewswire/ -- DOSIsoft, leading provider of patient-specific imaging and dosimetry software solutions for radiation oncology and nuclear medicine, proudly announces the latest release of PLANET® Onco Dose version 3.2 – multi-radionuclide, personalized, voxel-based dosimetry platform for SIRT and MRT – now approved for market in EU under CE MDR...
Over 250 million people worldwide unaware they have diabetes, according to new research from the International Diabetes Federation (IDF)
New estimates from the IDF Diabetes Atlas highlight the growing diabetes threat, with nearly one in nine adults now living with the condition. BRUSSELS, April 7, 2025 /PRNewswire/ -- Globally, nearly one in nine adults (589 million) are now living with diabetes. Of these, an estimated 252 million are not yet aware...
World Health Day Focus: Yeast Protein for Muscle Gain Unveiled through Scientific Clinical Trials
YICHANG, China, April 7, 2025 /PRNewswire/ -- In recognition of World Health Day 2025, themed "Healthy Beginnings, Hopeful Futures," Angel Yeast (SH600298), an innovation-driven global biotechnology brand, is championing inclusive health solutions that transcend gender, age, and geography. At the heart of this commitment is its breakthrough Yeast Protein, a sustainable and scientifically...
Duality Bio Appoints Hua Mu as Global Chief Medical Officer
SHANGHAI, April 7, 2025 /PRNewswire/ -- DualityBio announced today that Dr. Hua Mu has joined the company as Global Chief Medical Officer (CMO). In this role, Dr. Mu will oversee the strategic planning, meticulous design, efficient execution, and comprehensive regulatory compliance of the company's global clinical development efforts, ensuring adherence to the most...
Healthy Beginnings, Hopeful Futures
World Health Day Statement by Education Cannot Wait Director Yasmine Sherif NEW YORK, April 7, 2025 /PRNewswire/ -- Education is an essential investment in providing health to those left furthest behind. On World Health Day, we must connect the dots between education and health in humanitarian crisis settings. A child attending school gets vaccinations and healthcare, a nutritious...
Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with Its CT 3500 Imaging Solution
Philips CT 3500, a scalable, adaptable, and durable imaging solution, improves efficiency and care quality, optimizes patient and user experience, and enhances clinical outcomes and operational efficiency. SAN ANTONIO, April 7, 2025 /PRNewswire/ -- Frost & Sullivan recently assessed the AI-enabled CT systems industry and, based on its findings, recognizes Philips with the 2024 Asia-Pacific New Product Innovation Award. Over...
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL Bio's Grabody-B platform technology to effectively deliver molecules across the blood-brain barrier - ABL Bio to receive up to £77 million in upfront and near-term payments SEONGNAM, South Korea,...
Luye Pharma Announces U.S. Launch of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Schizoaffective Disorder
PRINCETON, N.J., April 7, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI® (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in the U.S. for the treatment of adults with schizophrenia and as a monotherapy or adjunct therapy for the treatment of adults with schizoaffective disorder. ERZOFRI, administered once a month, delivers the active ingredient, paliperidone,...
George Clinical Rebrands as Emerald Clinical Trials
New name reflects company's growth and vision to help bring certainty and transparency to global clinical trials SINGAPORE, April 7, 2025 /PRNewswire/ -- George Clinical, a leading clinical research organization (CRO) operating worldwide, is pleased to announce it has rebranded to become Emerald Clinical Trials. This strategic name change underscores the company's well-established position...
